Compare Kohl's Corporation (KSS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kohl's Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Kohl's Corporation trades at $18.13 (market cap $1.99B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 8.7× Kohl's Corporation's market cap, and Kohl's Corporation pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| KSS | ZBH | |
|---|---|---|
Market Cap | $1.99B | $17.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.71 | $107.71 |
52-Week Low | $10.42 | $79.58 |
Enterprise Value | $8.10B | $24.40B |
Dividend Yield | 2.85% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kohl's (KSS) trades at $18.12, up 4.74% recently, with a bullish technical signal from moving averages and a consensus analyst price target of $16.75. The stock shows low valuation multiples with a P/E of 7.38 and P/S of 0.13, while recent earnings have beaten expectations. Revenue has declined from $19.4B in 2022 to $16.2B in 2025, but net income improved to $109M. The company is focusing on proprietary brands and operational improvements under new leadership.
The outlook suggests a turnaround opportunity with attractive valuations and recent operational progress, but risks include persistent revenue declines and competitive pressures. Investor sentiment is mixed, with analysts divided between buy and hold ratings. Upside depends on successful execution of the company's revitalization strategy amid a challenging retail environment.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
